Shopping Cart 0
Cart Subtotal
USD 0

Lawson Health Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Lawson Health Research Institute (Lawson) is a hospital-based research institute that offers educational and research programs. The institute' services include health research programs, medical research programs, educational research programs, scientific research programs, patient care services, medical care, clinical trials and healthcare services. It also provides surgical technologies and advanced robotics services, clinical research, cancer research, clinical investigations and therapeutics, cyclotron and pet radiochemistry, kidney clinical research, renal health discovery and translation services. Lawson offers cancer research laboratory programs, children's health research, diabetes and endocrinology, critical illness, mental health research, imaging and microbiome and probiotics services, among others. The institution provides its services through its centers, facilities and medical departments. Lawson is headquartered in London, Ontario, Canada.

Lawson Health Research Institute-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Lawson Health Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deal Details 10

Licensing Agreements 10

StemCell Technologies Enters into Licensing Agreement with Lawson Health Research Institute 10

Yabao Pharma Enters into Licensing Agreement with Lawson Health Research Institute 11

Novare Pharma Enters into Licensing Agreement with Lawson Health Research Institute 12

Lawson Health Research Institute-Key Competitors 13

Lawson Health Research Institute-Key Employees 14

Lawson Health Research Institute-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Government and Public Interest 16

Oct 24, 2018: New clinical protocol after general surgery cuts opioid prescribing in half 16

Jul 11, 2018: Health researchers in London bring in over USD 11 million of national funding 17

May 03, 2018: Researchers find gut microbiome plays an important role in atherosclerosis 18

Apr 25, 2018: How the brain is folded provides researchers with an accurate marker to predict psychosis in high-risk patients 19

Mar 05, 2018: Early psychosis programs significantly reduce patient mortality, study finds 20

Feb 26, 2018: Lawson researchers receive USD 4.4 million to study personalized medicine at LHSC 22

Jan 29, 2018: New radiation techniques could improve quality of life for lung cancer patients 24

Jan 25, 2018: London researchers net over USD 8.6 million in CIHR funding 25

Other Significant Developments 26

Jul 09, 2018: Synthetic surfactant could ease breathing for patients with lung disease and injury 26

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Key Facts 2

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Lawson Health Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Lawson Health Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8

Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

StemCell Technologies Enters into Licensing Agreement with Lawson Health Research Institute 10

Yabao Pharma Enters into Licensing Agreement with Lawson Health Research Institute 11

Novare Pharma Enters into Licensing Agreement with Lawson Health Research Institute 12

Lawson Health Research Institute, Key Competitors 13

Lawson Health Research Institute, Key Employees 14

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Lawson Health Research Institute, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.